Efficacy and safety of hyperbaric oxygen treatment... (2022 study) Skip to main content
Systematic Review Diving Hyperb Med 2022 Canadian

Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update

Boet S, Etherington C, Ghanmi N, Ioudovski P, Tricco A, Sikora L, et al., Diving Hyperb Med, 2022

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

The researchers updated an earlier review by searching for new studies, published between 1 February 2021 and 1 April 2022, on hyperbaric oxygen treatment (HBOT) for COVID-19 patients with low blood oxygen.

What They Found

This living systematic review update found that all eight included studies, covering 224 patients, reported improved clinical outcomes with HBOT and no serious adverse events. Two new studies were added, both randomised controlled trials, enrolling 127 patients. One of these had a moderate risk of bias and one had a high risk of bias. Across the eight studies, 114 patients received HBOT. The authors did not combine the results in a meta-analysis because the studies differed too much and reported their data incompletely.

What This Means for Canadian Patients

The review looked only at people with acute COVID-19 and low blood oxygen. For them, the authors concluded that the studies give further evidence on the safety and effectiveness of HBOT. Because the results could not be pooled and two of the newest trials carried moderate or high risk of bias, patients should read this as an early picture and discuss any treatment decision with their own doctor.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The studies varied widely and reported incompletely, so the results could not be pooled, and the two newest trials had a moderate or high risk of bias.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Systematic Review
Category COVID-19 / Long COVID
Source Pubmed
PubMed ID 35732285
Year Published 2022
Journal Diving Hyperb Med
MeSH Terms COVID-19; Humans; Hyperbaric Oxygenation; Oxygen; Pandemics; Treatment Outcome

Cite This Study

Share

This study relates to Long COVID. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology